Please Wait.....
Report
Global Gynecology Drugs Market, By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2027
Market Report I 2022-07-01 I 199 Pages I TechSci Research
The global gynecology drugs market was valued at USD14139.56 million in 2021 and is expected to grow at a steady CAGR of 8.64% in the forecast period, 2023-2027, to reach USD21395.67 million by 2027. The market is driven by the increased incidences of gynecological diseases and the rise in the elderly female population. Also, the high-end investments by the public and private players in research and development activities to improve the effectiveness of drugs and eliminate the side effects are expected to create lucrative growth opportunities for the global gynecology drugs market in the forecast period.
The rise in the female old age population is expected to fuel the demand for gynecology drugs as they are more prone and are at higher risk of getting affected by gynecological disorders. According to the World Population Prospects in 2021, about 9.5% of females above the age group of 60 years are vulnerable to getting affected by gynecological disorders. The growing old-age population is expected to fuel the demand for the global gynecology drugs market in the forecast period.
The global gynecology drugs market is segmented into therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on regional distribution, the North American region dominated the market in 2021 and held 35.09% of the overall market share. The presence of major market players and well-developed healthcare infrastructure are the primary drivers for the gynecology drugs market. Also, the increased prevalence of breast cancer, menopausal disorders, busy lifestyles, and high stress in women is accelerating the demand for gynecology drugs.
Major companies operating in the global gynecology market are Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals, amongst others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027
Objective of the Study:
- To analyze the historical growth and the market size of the global gynecology drugs market from 2017 to 2021.
- To estimate and forecast the market size of the global gynecology drugs market from 2023 to 2027 and growth rate until 2027.
- To classify and forecast the global gynecology drugs market is divided into therapeutics, indication, distribution channel, regional distribution, and competitive landscape.
- To identify drivers and challenges for the global gynecology drugs market.
- To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global gynecology drugs market.
- To conduct pricing analysis for the global gynecology drugs market.
- To identify and analyze the profile of leading players operating in global gynecology drugs market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading gynecology drugs manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the gynecology drugs manufacturers who could not be identified due to the limitations of secondary research. TechSci Research analyzed the gynecology drugs manufacturers, distribution channels and presence of all major players operating in the global gynecology drugs market all over the world.
TechSci Research calculated the global gynecology drugs market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
- Gynecology drugs manufacturers/ suppliers/ distributors
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to gynecology drugs
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as gynecology drugs manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.
Report Scope:
In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Gynecology Drugs Market, By Therapeutics:
o Non-Hormonal Therapy
o Hormonal Therapy
- Gynecology Drugs Market, By Indication:
o Contraception
o Gynecology Infections
o Female Infertility
o Postmenopausal disorders
o Polycystic Ovary Syndrome
o Osteoporosis
o Gynecology Cancers
o Endometriosis
o Others (Urogenital Malformation, UTI & others)
- Gynecology Drugs Market, By Distribution Channel:
o Retail Pharmacies
o Hospital Pharmacies
o Online Pharmacies
- Gynecology Drugs Market, By Region:
o North America
- United States
- Canada
- Mexico
o Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
o Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
4.1. Brand Awareness
4.2. Factors Affecting Purchase Decision
4.3. Product Preference, By Therapeutics
5. Impact of COVID-19 on Global Gynecology Drugs Market
6. Global Gynecology Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutics (Non-Hormonal Therapy vs Hormonal Therapy)
6.2.2. By Indication (Contraception, Gynecology infections, Female infertility, Postmenopausal Disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others)
6.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies Online Pharmacies)
6.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
6.2.5. By Company (2021)
6.3. Product Market Map
7. North America Gynecology Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutics
7.2.2. By Indication
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Gynecology Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapeutics
7.3.1.2.2. By Indication
7.3.1.2.3. By Distribution Channel
7.3.2. Canada Gynecology Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapeutics
7.3.2.2.2. By Indication
7.3.2.2.3. By Distribution Channel
7.3.3. Mexico Gynecology Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapeutics
7.3.3.2.2. By Indication
7.3.3.2.3. By Distribution Channel
8. Europe Gynecology Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutics
8.2.2. By Indication
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Gynecology Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapeutics
8.3.1.2.2. By Indication
8.3.1.2.3. By Distribution Channel
8.3.2. France Gynecology Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapeutics
8.3.2.2.2. By Indication
8.3.2.2.3. By Distribution Channel
8.3.3. United Kingdom Gynecology Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapeutics
8.3.3.2.2. By Indication
8.3.3.2.3. By Distribution Channel
8.3.4. Italy Gynecology Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapeutics
8.3.4.2.2. By Indication
8.3.4.2.3. By Distribution Channel
8.3.5. Spain Gynecology Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapeutics
8.3.5.2.2. By Indication
8.3.5.2.3. By Distribution Channel
9. Asia Pacific Gynecology Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutics
9.2.2. By Indication
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. Asia Pacific: Country Analysis
9.3.1. China Gynecology Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapeutics
9.3.1.2.2. By Indication
9.3.1.2.3. By Distribution Channel
9.3.2. Japan Gynecology Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapeutics
9.3.2.2.2. By Indication
9.3.2.2.3. By Distribution Channel
9.3.3. India Gynecology Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapeutics
9.3.3.2.2. By Indication
9.3.3.2.3. By Distribution Channel
9.3.4. Australia Gynecology Drugs Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Therapeutics
9.3.4.2.2. By Indication
9.3.4.2.3. By Distribution Channel
9.3.5. South Korea Gynecology Drugs Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Therapeutics
9.3.5.2.2. By Indication
9.3.5.2.3. By Distribution Channel
10. South America Gynecology Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapeutics
10.2.2. By Indication
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Gynecology Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapeutics
10.3.1.2.2. By Indication
10.3.1.2.3. By Distribution Channel
10.3.2. Argentina Gynecology Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapeutics
10.3.2.2.2. By Indication
10.3.2.2.3. By Distribution Channel
10.3.3. Colombia Gynecology Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapeutics
10.3.3.2.2. By Indication
10.3.3.2.3. By Distribution Channel
11. Middle East and Africa Gynecology Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Therapeutics
11.2.2. By Indication
11.2.3. By Distribution Channel
11.2.4. By Country
11.3. Middle East and Africa: Country Analysis
11.3.1. South Africa Gynecology Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Therapeutics
11.3.1.2.2. By Indication
11.3.1.2.3. By Distribution Channel
11.3.2. Saudi Arabia Gynecology Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Therapeutics
11.3.2.2.2. By Indication
11.3.2.2.3. By Distribution Channel
11.3.3. UAE Gynecology Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Therapeutics
11.3.3.2.2. By Indication
11.3.3.2.3. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends and Developments
14. Competitive Landscape
14.1. Company profiles
14.1.1. Eli Lilly and Company Ltd.
14.1.2. Pfizer Inc.
14.1.3. Merck & Co., Inc.
14.1.4. Amgen Inc.
14.1.5. AstraZeneca Plc
14.1.6. F. Hoffmann-La Roche Ltd.
14.1.7. Allergan Plc.
14.1.8. Bayer AG
14.1.9. Abbott Laboratories Ltd.
14.1.10. AbbVie Inc.
14.1.11. GlaxoSmithKline Plc
14.1.12. Novartis Ltd.
14.1.13. Lupin Pharmaceuticals, Inc.
14.1.14. Johnson and Johnson Inc.
14.1.15. Sanofi SA
15. Strategic Recommendations
Figure 1: Global Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 2: Global Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 3: Global Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 4: Global Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 5: Global Gynecology Drugs Market Share, By Region, By Value, 2017-2027F
Figure 6: Global Gynecology Drugs Market Share, By Company, By Value, 2021
Figure 7: Global Gynecology Drugs Market Map, By Therapeutics, Market Size (USD Million) & Growth Rate (%), 2021
Figure 8: Global Gynecology Drugs Market Map, By Indication, Market Size (USD Million) & Growth Rate (%), 2021
Figure 9: Global Gynecology Drugs Market Map, By Distribution Channel, Market Size (USD Million) & Growth Rate (%), 2021
Figure 10: Global Gynecology Drugs Market Map, By Region, Market Size (USD Million) & Growth Rate (%), 2021
Figure 11: North America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 12: North America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 13: North America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 14: North America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 15: North America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 16: United States Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 17: United States Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 18: United States Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 19: United States Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 20: Canada Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 21: Fertility Rate in Canada, 2005, 2010, 2015, 2020
Figure 22: Canada Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 23: Canada Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 24: Canada Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 25: Mexico Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 26: Mexico Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 27: Mexico Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 28: Mexico Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 29: Europe Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 30: Europe Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 31: Europe Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 32: Europe Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 33: Europe Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 34: Germany Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 35: Fertility Rate in Germany, 2005, 2010, 2015, 2020
Figure 36: Germany Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 37: Germany Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 38: Germany Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 39: France Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 40: France Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 41: France Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 42: France Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 43: United Kingdom Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 44: Prevalence of Menopause Symptoms Experienced by Women at Work in United Kingdom, 2021
Figure 45: United Kingdom Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 46: United Kingdom Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 47: United Kingdom Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 48: Italy Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 49: Fertility Rate in Italy, 2005, 2010, 2015, 2020
Figure 50: Italy Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 51: Italy Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 52: Italy Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 53: Spain Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 54: Spain Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 55: Spain Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 56: Spain Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 57: Asia Pacific Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 58: Asia Pacific Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 59: Asia Pacific Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 60: Asia Pacific Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 61: Asia Pacific Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 62: China Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 63: China Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 64: China Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 65: China Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 66: Japan Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 67: Estimated Share of Women in Japan Using any Contraceptive Method, 2005, 2010, 2015, 2020
Figure 68: Japan Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 69: Japan Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 70: Japan Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 71: India Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 72: Polycystic Ovary Syndrome Issues Among Women Across India, By Age Group, 2020
Figure 73: India Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 74: India Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 75: India Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 76: Australia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 77: Australia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 78: Australia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 79: Australia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 80: South Korea Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 81: South Korea Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 82: South Korea Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 83: South Korea Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 84: South America Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 85: South America Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 86: South America Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 87: South America Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 88: South America Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 89: Brazil Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 90: Fertility Rate in Brazil, 2005, 2010, 2015, 2020
Figure 91: Brazil Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 92: Brazil Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 93: Brazil Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 94: Argentina Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 95: Total Female Population of Argentina, by Age Group, 2020 (in Millions)
Figure 96: Argentina Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 97: Argentina Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 98: Argentina Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 99: Colombia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 100: Colombia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 101: Colombia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 102: Colombia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 103: Middle East & Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 104: Middle East & Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 105: Middle East & Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 106: Middle East & Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 107: Middle East & Africa Gynecology Drugs Market Share, By Country, By Value, 2017-2027F
Figure 108: South Africa Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 109: Fertility Rate in South Africa, 2005, 2010, 2015, 2020
Figure 110: South Africa Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 111: South Africa Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 112: South Africa Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 113: Saudi Arabia Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 114: Saudi Arabia Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 115: Saudi Arabia Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 116: Saudi Arabia Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Figure 117: UAE Gynecology Drugs Market Size, By Value (USD Million), 2017-2027F
Figure 118: Total Female Population of UAE, by Age Group, 2020 (in Millions)
Figure 119: UAE Gynecology Drugs Market Share, By Therapeutics, By Value, 2017-2027F
Figure 120: UAE Gynecology Drugs Market Share, By Indication, By Value, 2017-2027F
Figure 121: UAE Gynecology Drugs Market Share, By Distribution Channel, By Value, 2017-2027F
Table 1: Infertility Statistics of United States
Table 2: Ovary Cancer Cases in Mexico, 2020
Table 3: Ovary Cancer Cases in France, 2020
Table 4: Ovary Cancer Cases in Spain, 2020
Table 5: Ovary Cancer Cases in China, 2020
Table 6: Cancer Statistics of Australia, 2020
Table 7: Ovary Cancer Cases in South Korea, 2020
Table 8: Ovary Cancer Cases in Colombia, 2020
Table 9: Cervix Uteri Cancer Cases in Saudi Arabia, 2020
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security